Cardiology
More than half had silent atherosclerosis. Standard risk scores missed many of them
The REACT study found silent atherosclerosis in 57.1% of more than 16,800 adults without known cardiovascular disease, including around 1 in 13 people aged 18 to 29. Conventional SCORE2 assessment classified only a small minority of participants with imaging-detected disease as high risk, raising a difficult precision-medicine question: should prevention continue to be driven mainly…
Cardiac rehabilitation is now explicitly personalised in Europe. Reimbursement could decide who gets it
AI can find hidden heart disease in routine ECGs. The policy challenge is deciding who gets fast-tracked
Nearly two-thirds showed no measurable fitness gain after short cardiac rehab. AI may identify who needs a different plan
Heart attack survival is only the beginning. AI identified three very different five-year health trajectories
Bayer’s ESC 2026 programme puts the heart-kidney axis centre stage. Disease silos are starting to look obsolete
Four in five young adults in an urban U.S. cohort had CKM risk factors. Cardiovascular prevention is arriving too late
Can an hour of exercise undo eight hours of sitting? The heart-health evidence is more complicated
Borderline blood pressure is not harmless. The mistakes that let cardiovascular risk build quietly
The first oral PCSK9 inhibitor is approved. A pill will not fix cholesterol access by itself
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.